Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases

By Amina Niasse NEW YORK, June 11 (Reuters) – Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)